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Abstract
Psychogenic pseudosyncope (PPS) is a common cause of apparent transient loss of conscious-
ness (TLOC) with a dramatic impact on the quality of life. This review aims to give an over-
view of the definition, incidence, etiology, diagnosis, treatment, and prognosis of PPS based on 
a combination of literature data and personal experience. The limited literature on the subject 
suggests that PPS is relatively common but insufficiently recognized. PPS is probably similar 
to psychogenic nonepiteptic seizures (PNES), in which a long delay to diagnosis worsens the 
prognosis. A detailed history is of paramount importance for the diagnosis. The key feature in 
the history of patients with PPS is the occurrence of frequent, long attacks of apparent TLOC 
with closed eyes. The diagnosis is certain when a typical event is recorded during a tilt-table 
test with simultaneous blood pressure (BP), heart rate and video-electroencephalographic re-
cordings. Home video and BP recording during an attack can be very useful. The diagnosis 
should be communicated to the patient in a way that is clear, understandable and does not 
cause offense. Although treatment options have not been investigated formally, the literature on 
PNES suggests that cognitive behavioral therapy is beneficial. (Cardiol J 2014; 21, 6: 658–664)
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Introduction: Psychogenic apparent  
loss of consciousness
Transient loss of consciousness (TLOC) is 
a common clinical problem, consisting of three major 
groups: syncope, epileptic seizures, and psychoge-
nic attacks, along with a rest group of remaining 
symptoms like mimics and rare disorders [1, 2]. 
The 2009 European Society of Cardiology (ESC) 
Guidelines on syncope define TLOC as an ‘apparent 
loss of consciousness’ [2]. The word ‘apparent’ was 
explicitly added to allow psychogenic disorders to 
be included. In TLOC, due to syncope and epileptic 
seizures consciousness is undeniably lost, whereas 
there is no demonstrable cerebral dysfunction in 
psychogenic TLOC. For that reason such attacks 
might be classified as wholly separate from seizu-
res and syncope, which was the case in the first 
ESC guidelines on syncope. They were later bun-
dled because syncope, seizures and psychogenic 
attacks can be mistaken for one another and feature 
in the same differential diagnosis.
Patients who suffer from recurrent episodes 
of psychogenic TLOC can present with a wide 
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range of clinical symptoms. Some attacks are cha-
racterized by pronounced movements resembling 
epileptic seizures, generally labelled psychogenic 
non-epileptic seizures (PNES). When there are 
no discernible movements, the attacks are more 
easily mistaken for syncopal events. Labels for 
these attacks include psychiatric syncope, psycho-
genic syncope, pseudosyncope and psychogenic 
pseudosyncope (PPS). By definition [2], syncope 
is caused by cerebral hypoperfusion so this term 
should not be used for psychogenic attacks as they 
are not accompanied by changes in brain circula-
tion. We prefer PPS because, analogous to PNES, 
it describes what the attack mimics while also 
indicating its nature.
PNES and PPS share the same underlying psy-
chological disorder, but the difference in symptoms 
affects how the patient is diagnosed and managed. 
Patients with PNES are likely to be referred to neu-
rologists, among whom PNES is well-known. The 
prevalence of PNES ranges from 18% in patients 
with seizures in a community study [5] up to 32% 
in patients in epilepsy clinics [6]. Patients with PPS 
are more likely to be referred to cardiologists in 
search for a cause of the presumed syncope. Table 1 
lists the prevalence of various causes of TLOC in 
a number of cohort studies. Compiling diagnoses 
from 10 syncope units resulted in a mean rate of 
PPS of 4%, but the prevalence varied greatly be-
tween series: several large cohort studies reported 
0% PPS whereas others report a prevalence of up to 
12%. This wide range in the prevalence of PPS sug-
gests that it is possibly insufficiently recognized, as 
has been suggested by others [14, 15]. Publications 
Table 1. Relative frequencies of diagnosis in syncope units. The table describes finding of the major 
apparent transient loss of consciousness (TLOC) categories. Note that percentages per study need not 
add to 100%, as some categories used in the papers may have been left out. Several large cohort  
studies reported no cases of psychogenic syncope (PPS). Adapted from Wieling et al. [3].
Source N Setting Classification 
system
VVS 
(%)
OH  
(%)
Cardiac 
(%)
Epileptic  
seizures (%)
PPS 
(%)
Unexplained 
(%)
Brignole et al.,  
2003 [4]
279 ED with  
syncope unit 
(6 centers)
ESC 2001 56 4 8 ≤ 152 16
Strano et al.,  
2005 [7]
521 Outpatient Syncope  
is TLOC 1
53.6 6.3 2.5 1.3 2.9 8.4
Brignole et al.,  
2006 [8]
712 19 general 
hospitals
ESC 2001 65 10 13 ≤ 62 5
Ammirati et al.,  
2008 [9]
96 In- and  
outpatients
ESC 2009 65 1 6 13 1 18
Brignole et al.,  
2010 [10]
941 9 general 
hospitals
ESC 2004 67 4 6 1 1 18
Mitro et al.,  
2011 [11]
501 Teaching 
hospital
ESC 2009 46.2 4.8 35.3 0 1.4 10.9
Sousa et al.,  
2013 [12]
245 General  
hospital,  
in- and  
outpatient 
ESC 2009 52.2 15.6 20.0 0 0 12.2
Shin et al.,  
2013 [13]
128 ED, training 
hospital 
‘Largely  
ESC 2009’
65.5 11.7 8.2 0 0 12.5
Wieling, 2014,  
unpublished 
1651 Outpatient 
tertiary  
referrals 
ESC  
2001–2009
67.5 14.9 0.8 0.8 10.2 5.7
Van Dijk, 2014,  
unpublished 
174 Outpatient 
tertiary  
referrals
ESC 2009 54.6 19.0 0.6 4.64 12.1 6.3
Mean and range       59.3 
(46.2– 
–67.5)
9.1  
(1– 
–19.0)
10.4 
(0.6– 
–35.3)
1.1  
(0–4.6)
3.6  
(0– 
–12.1)
11.3  
(5–18)
ED — Emergency Department; ESC — European Society of Cardiology; OH — orthostatic hypotension; VVS — vasovagal syncope 
1Syncope defined as ‘transient loss of consciousness with loss of postural muscle tone’
2Includes epileptic seizures, psychogenic pseudosyncope and other conditions
3Carotid sinus syndrome + epilepsy
4Includes ‘epileptic syncope’, i.e. asystole due to an epileptic seizure
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on PPS are also scarce. This could have a number of 
explanations: (1) PPS is indeed very rare, (2) It is 
not recognized and patients are diagnosed with an 
‘unexplained syncope’ instead, or (3) The subject 
is not considered exciting enough from a scientific 
point of view.
Etiology of PPS
PNES and PPS can be regarded as conver-
sion disorder, a disease that is characterized by 
neurologic symptoms (in this case apparent loss of 
consciousness) that are not caused by a neurologic 
disease, but cause distress and/or impairment [16]. 
Psychological factors or life events such as trauma, 
interpersonal conflicts, and recent or old stressors 
may be associated with onset of conversion disorder. 
However, psychological factors and trauma are not 
always reported by patients, nor are they specific to 
conversion disorder, and many patients with conver-
sion symptoms may not have identifiable psycholo-
gical stressors. There is some evidence that altered 
preconscious threat processing causes a state of 
hypervigilance in patients who suffer from PNES 
[17]. During psychogenic apparent TLOC, heart 
rate (HR) and blood pressure (BP) are significantly 
increased [18]. This suggests that the episodes are 
accompanied by acute psychological stress [19]. PPS 
occurs in both sexes at all ages, although it appears 
to be more common in young women [18].
Diagnosing PPS: History taking
The importance of an accurate diagnosis is well 
established in the literature on PNES [20] but has 
not yet been explored in PPS. In PNES, a diagno-
stic delay can have serious adverse effects, even 
including death [21]. The delay until the correct 
diagnosis is typically stated as being several years 
[20]. Misdiagnosed PNES patients will be started 
on anti-epileptic drugs, and only the failure of a tre-
atment response will in time prompt physicians to 
reconsider the diagnosis. The prognosis of PNES is 
worse as the delay to diagnosis is longer [22]. Once 
PNES is diagnosed there is a strong reduction in 
emergency department visits, hospital admissions, 
ambulance calls, magnetic resonance imaging scans, 
computed tomography scans and electroencepha-
lography (EEG), implying that there are economic 
benefits to making a timely diagnosis [23, 24]. The 
delay between attack onset and diagnosis in PPS 
has not been studied in depth but may be shorter 
than in PNES, as no erroneous drug treatment will 
be started. Still, a deleterious effect of a long delay 
seems as likely as in PNES.
Due to the transient nature of TLOC, attacks 
are not likely to be witnessed by doctors, and 
the presence of amnesia makes an eyewitness 
account crucial. Unfortunately, distressed eye-
-witnesses tend to overlook or inaccurately recall 
salient features [25]. Accounts are probably more 
reliable as more attacks have been witnessed, 
but even then physicians may not know which 
signs and symptoms to ask for. Recently, we have 
described the semiology of PPS based on the 
analysis of consecutive episodes of tilt-evoked 
psychogenic apparent TLOC. In these observed 
attacks of PPS, the eyes were virtually always 
closed (97%) during apparent TLOC, in contrast 
to vasovagal syncope (VVS) (7%) (Figs. 1, 2). 
Typically, PPS was characterized by a sudden loss 
of muscle tone (e.g., falling, dropping the head); 
this was less common in VVS [18]. In contrast, 
jerking movements were rarely seen in PPS, 
but occurred in approximately 60% of patients 
with VVS [26]. Finally, PPS can be distinguished 
from VVS using the duration of apparent TLOC, 
which is longer in PPS. When it lasts longer than 
1 min, PPS is far more likely than VVS [18].
Our personal experience with the history of 
approximately 100 cases fits well with these ob-
servations: attacks are frequent, may often occur 
more than once a day, and last for a long time. 
The high number and long duration of attacks 
often allow reliable eyewitness accounts, yielding 
descriptions of the attack as an unresponsive 
and immobile state. Eyewitnesses may describe 
Figure 1. Typical tilt-table measurements of a patient with 
vasovagal syncope (right). The start of clinically apparent 
transient loss of consciousness (TLOC) is marked with 
a black line. Both heart rate (HR) and blood pressure (BP) 
show an accelerating drop and reach their minimum 
around the start of TLOC.
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attacks lasting 30 min or even longer. Oddly, many 
physicians will still consider syncope as a cause, 
even though global cerebral hypoperfusion lasting 
30 min is not compatible with a normal neurolo-
gical state immediately afterwards. When asked 
about the patient’s posture during an attack, wit-
nesses may report a sleep-like state, with perhaps 
an arm under the head and closed eyes. Witnesses 
may even report seeing the eyes move behind the 
eyelids. Facial color is either reported as normal 
or slightly pale, but the extreme pallor seen in 
VVS is never described. In contrast to patients 
with VVS, those with PPS often report that they 
lack prodromal features. As a consequence, they 
are not able to prevent TLOC by sitting or lying 
down. Early on, patients may be seen by ambulan-
ce personnel or brought to emergency rooms. It is 
important to ask whether a BP measurement was 
obtained during apparent unconsciousness. Even 
when such an ictal measurement was normal, 
the implications for the diagnosis, in excluding 
syncope and pointing towards PPS, are often left 
undiscussed.
Over time, relatives will refrain from calling 
an ambulance, having learned that this does not 
result in a diagnosis or treatment. Early attacks 
are accompanied by extreme distress around the 
attack in relatives, over time giving way to un-
rest about the lack of diagnosis and stress about 
the consequences rather than about the attacks 
themselves.
Of note, patients themselves may not always 
have a complete amnesia for the event; some may 
hear part of what is going on around them, but wit-
hout an ability or inclination to act. This valuable 
diagnostic information may remain hidden unless 
it is asked for specifically. PPS can cause physical 
trauma, so neither the absence nor the presence 
of trauma is diagnostically reliable.
The literature on the semiology of PNES is 
more extensive than that of PPS and provides in- 
sights that may help the recognition of PPS as well. 
A number of signs that can be used to distinguish 
PNES from epilepsy have been identified with the 
use of prolonged video-EEG recordings. Signs 
with a > 90% specificity for PNES include: long 
attack duration, closed eyes during apparent TLOC, 
a fluctuating course, asynchronous or side-to-side 
movements, pelvic thrusting and ictal weeping. 
Conversely, stertorous breathing and postictal 
confusion are more than 90% specific for epilepsy 
[27]. It should be noted that this only held for video 
observations, not for eyewitness accounts [25].
Diagnosing PPS: Additional tests
While it is possible to make the diagnosis from 
the history alone in typical cases of PPS, additional 
tests serve two purposes: to confirm the diagnosis, 
which also excludes other diagnoses and, perhaps 
most importantly, to convince patients, relatives 
and other physicians that the attacks are psycho-
logical in nature.
Both PNES and PPS can be diagnosed with 
certainty when there are no signs of cerebral dys-
function during an adequately documented attack. 
Recognition of the episode as a typical event by 
the patient or a relative present is an important re-
quirement to prevent false-positive test results. In 
the case of PNES, this is usually done with the use 
of continuous EEG monitoring, in which case the 
absence of epileptiform EEG phenomena is consi-
dered the gold standard [28]. Sometimes, additional 
video analysis is warranted to exclude frontal lobe 
seizures that may occur without discernible EEG 
changes [29]. The gold standards to differentiate 
PPS from true syncope are the absence of BP low 
enough to cause unconsciousness, and a normal 
EEG during the attack [2]. Unfortunately, BP can-
not be monitored continuously for long periods as 
easily as EEG, making it harder to obtain an ictal 
measurement in PPS. However, PPS is amenable 
to suggestion and can be provoked with the use 
of induction techniques or placebo maneuvers, 
leading to an attack in 90% of patients with PPS [15]. 
Figure 2. Typical tilt-table measurements of a patient 
with psychogenic pseudosyncope. The start of clinically 
apparent transient loss of consciousness (TLOC) is again 
marked with a black line. Both heart rate (HR) and blood 
pressure (BP) increase well before the attack, reaching 
a maximum at the start of clinically apparent TLOC.
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Tilt-table testing with continuous HR, BP, EEG 
and video monitoring is particularly useful: the 
tilting maneuver is sufficiently suggestive to elicit 
apparent TLOC in 81% of patients with PNES [30]. 
Furthermore, this approach enables the clinician 
to investigate the major causes of TLOC in one 
comprehensive test. HR and BP data can be used 
to rule syncope as a cause of TLOC, whereas video-
-EEG can be used to exclude epilepsy. Finally, the 
availability of video data not only helps in analyzing 
the semiology of the episode at a later time point, 
but can also be used to review the test together 
with the patient and a relative and confirm that 
a representative attack was captured. A clinical 
suspicion of PPS is a recognized indication for a 
tilt table test by the ESC [2].
Transcranial Doppler ultrasound of cerebral 
circulation has been advocated in combination 
with tilt-table testing to diagnose PPS [31]. When 
there is normal cerebral blood flow during appa-
rent TLOC, syncope can be ruled out as a cause. 
However, normal cerebral perfusion does not rule 
out epilepsy and systemic BP and HR suffice to 
differentiate PPS from syncope.
PPS does not exclude additional somatic 
diagnoses [32]. In a longitudinal cohort of tilt-table 
induced PPS, 29% of patients showed a mixed pat-
tern of PPS and VVS [18]. In this respect PPS also 
resembles PNES: the co-occurrence of epileptic 
seizures and PNES is well-known [20].
Mobile phones with video recording capability 
are a valuable tool to obtain objective information. 
If the nature of the attacks remains unclear after 
the first outpatient visit, we generally recommend 
that relatives of the patient try to make video 
recordings of the attacks. Furthermore, relatives 
are instructed to pay particular attention to the 
duration of unresponsiveness and the state of eye 
closure. The high frequency and long duration of 
the attacks make it likely that the attacks can be 
documented in this way. For the same reasons re-
latives may succeed in taking a BP recording with 
an automatic wrist device.
Communication of the diagnosis
Interview studies in PNES patients have 
shown that receiving the diagnosis is characterized 
by conflicting emotions, making it difficult to accept 
the neurologist’s explanation. Patients need to 
integrate their diagnosis into a personal narrative 
in order to accept it [33]. Great care should the-
refore be taken to communicate in a manner that 
is clear and understandable and does not cause 
offense [34]. It is important to emphasize that the 
physician communicating the diagnosis does not 
think that attacks involve willful deceit. Instead, we 
stress that (1) Patients are not “crazy” and do not 
produce attacks voluntarily: the attacks happen to 
them just like syncope or epilepsy would; (2) The 
attacks cause distress and 3) Psychogenic attacks 
are much more common than people think. In our 
experience, the psychological nature of the attacks 
is usually accepted by patients and relatives, pro-
vided that enough time is taken for explanation. 
There is some debate in the literature on whether 
past trauma should be brought up as a potential 
cause, as this may be traumatic for patients and 
a clear history of trauma is not always present [33]. 
Most experts suggest that potential psychologi-
cal causes should be brought up in very general 
terms, e.g., “we often see them in patients who 
are under a lot of stress” [35]. In our experience, 
such generalized statements are usually sufficient 
for patients to bring up past or actual traumatic 
experiences, provided that an environment of trust 
has been established. This then paves the way 
for a further referral for treatment of conversion 
disorder. We typically offer a repeat visit in 1 or 
2 weeks to repeat key elements and to allow patients 
and relatives to ask questions.
Treatment and prognosis of PPS
The clinical picture of a typical PPS sufferer is 
one of an individual in severe distress; the patient 
should receive prompt and adequate treatment 
accordingly. Unfortunately, systematic, long-term 
follow-up data of the natural course of PPS or on 
the effect of psychotherapy is not available.
From the PNES literature, there is eviden-
ce that receiving the diagnosis has a substantial 
short-term beneficial effect, with approximately 
one third of patients becoming seizure free and 
a majority experiencing a significant reduction. 
However, long-term follow-up studies show that 
a majority of patients relapse after an initial good 
response to the diagnosis (reviewed in [20]).
The efficacy of various treatments for PNES 
has recently been reviewed [36]. The efficacy of 
cognitive behavioral therapy had the highest level 
of evidence, including one pilot randomized con-
trolled trial comparing cognitive behavioral therapy 
with standard medical care. Other interventions 
with efficacy in uncontrolled trials included au-
gmented psychodynamic interpersonal psychothe-
rapy, group psychodynamic psychotherapy, group 
psycho-education, and selective serotonin reuptake 
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inhibitors (SSRI). A pilot study on the SSRI sertra-
line showed a non-significant trend towards lower 
PNES event frequencies [37]. This was followed 
up by a multi-center randomized but unblinded 
clinical trial that compared cognitive behavioural 
therapy with and without flexible-dose sertraline to 
treatment as usual for PNES. Cognitive behavioral 
therapy resulted in improvement but the sertraline 
and usual treatment groups did not [38].
However, the most relevant treatment pa-
rameter is probably quality of life and perhaps 
occupational status, rather than attack frequency 
[39]. The scarce literature studying these parame-
ters suggests that they rarely show improvement 
in PNES [20].
Data on the prognosis of PPS are not available. 
In PNES, several factors have been shown to have 
a positive influence on long-term prognosis (review- 
 ed in [35]): the absence of severe psychiatric co-
morbidity, identifiable acute psychological trauma 
preceding the onset of PNES, living independently, 
a normal IQ, higher socio-economic class, being 
female, younger age, no past history of violence 
and a short history of PNES [22].
Conclusions
PPS is a serious condition with a dramatic 
impact on the quality of life. There are suggestions 
in the literature that it is insufficiently recognized 
and that this likely causes a delay in treatment with 
a potential negative effect on the outcome. PPS 
should be considered in all patients who suffer from 
episodes of apparent TLOC of unknown origin. 
A detailed history is of paramount importance for 
the diagnosis. Important aspects of the history 
are frequency, duration and eye closure: frequent, 
long attacks with the eyes closed during apparent 
TLOC are pathognomonic for PPS. The diagnosis 
can be made with certainty when a typical event is 
recorded during a tilt-table test with simultaneous 
BP, HR and video EEG recordings. Ictal home 
video and BP recording can be very useful. Once 
the diagnosis is made, it should be communicated 
to the patient in a way that is understandable and 
does not cause offense. Although treatment options 
have not been investigated in well-designed rando-
mized clinical trials, there is some evidence from 
the literature on PNES that cognitive behavioral 
therapy is beneficial.
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